Summary The data for this study, consisting of 300 females treated for breast cancer in [1951][1952][1953][1954][1955][1956][1957][1958][1959][1960][1961] 
There is an increasing awareness among cancer investigators that breast cancer may be a systemic disease from its inception (Strax, 1978) . There is also increasing evidence that its initial clinical manifestation in the vast majority of cases is a localized lesion in one breast, although there may be evidence of microscopic totally occult dissemination elsewhere (Strax, 1978) . That is why a patient who is still alive five years after the treatment for breast cancer cannot be considered to be 'cured' even if she seems to be disease free. The risk of dying from breast cancer decreases the longer the patient survives (Blackwood et al., 1977) , and if breast cancer is detected and treated effectively at a very early stage there is a 90% probability of survival over a twenty year period (Frazier et al., 1977 Hospital. The 5 year survival rates were published in 1969 (Peltokallio et al., 1969) . The age distribution of the patients is presented in Figure 1 . 90 Age Figure 1 The age distribution of the patients.
©) The Macmillan Press Ltd., 1986 (Breslow & Day, 1982) , comparing the death rates to the population of all Finnish females of the same age in the same time period (Central Statistical Office of Finland, 1984) . The causes of death were verified from the death certificates.
Results
The patients were divided into different stages by TNM-classification. The overall survival rate for the entire material is presented in Figure 2 . The crude mortality rate is compared to the mortality in the normal Finnish female population of the same age. The 'corrected' rate (referring only to breast 1 Time (years) Figure 2 The overall survival rate for the whole material (log scale). I-expected, 2-'corrected', 3-ageadjusted and 4-crude. cancer mortality, excluding other causes of death) and the age-adjusted rate for the patients who died of breast cancer are also given. Seventy-one (24%) of the patients survived twenty years or more. Only 56% of the 300 females died of breast cancer. The crude curve and the expected curve show approximately the same slope starting about 10 years after the primary treatment, which signifies almost complete disappearance of excess mortality from breast cancer. The crude and 'corrected' survival rates in different clinical stages are presented in Figure 3 . The crude 20 year survival rate in stages I-III was 46, 23 and 11%, respectively. The ageadjusted results at 10 years were 65, 45 and 18%, and at 20 years 71, 36 and 15%, respectively. However, only 26% of the 70 patients with stage I disease died of breast cancer. For stage II patients the respective figure was 57% of the 147 patients, and for stage III patients, 70% of the 61 patients. Every patient with stage IV died within 5 years. Twenty-one of the 22 patients in this group died of breast cancer. The crude 20 year survival rate in different T-groups is presented in Figure 4 . The proportion of breast cancer among causes of death in different groups is presented in Table II (Fisher et al., 1985) . The ten year survival rate estimated by the actuarial life-table method was 57% for the patients with MO and clinically negative axillary nodes, and 38% for those with clinically positive nodes. The corresponding crude results in our material were 55 and 38%, respectively. It therefore seems that the choice between local and radical treatment is not of importance with respect to the survival of patients with breast cancer. However, the present trend in the treatment of breast cancer in Finland is more conservative.
According to our study, the size of the tumour had a significant effect on the prognosis, especially according to the long term follow-up. (With TI the twenty year survival rate was 37%, with T2, 24% and with T3-4, 17%; P<0.001). However, it has been shown that it is not sufficient to estimate the prognosis purely on the basis of the size of the tumour, especially in the case of small cancers (Bedwani et al., 1981) . The status of axillary nodes may determine whether or not a small invasive tumour less than one centimeter in diameter may be considered a minimal cancer.
The long term prognosis for breast cancer patients is especially dependant on the clinical stage of the disease at the time of the primary diagnosis. In this study the crude ten year survival rate in stages I-IV was 55, 38, 16 and 0%, respectively. In several studies involving modified or radical mastectomy with or without postoperative radiotherapy the corresponding results were on the same level (Leis, 1979; Muir & White; 1967 , Nikkanen et al., 1981 Schottenfeld et al., 1976) .
Excess mortality from breast cancer continues twenty years after the primary treatment, although its proportion among deaths decreases with time (Hakulinen et al., 1982) . In a long-term study in the Cambridge area (UK) it has been shown that even after 20 years follow-up there are 16 times more deaths from breast cancer than expected in the normal population, although the overall death rates in the two groups were the same (Brinkley & Haybittle, 1975) . The trend was also confirmed on the basis of our material. The excess mortality from breast cancer decreased especially after ten years, when the survival curves almost paralleled the expected curves. A study of the hazard function or force of mortality from breast cancer revealed that the risk of dying of the cancer decreased the longer a patient survived (Blackwood et al., 1977) . This information is important. Our data show that for follow-up studies, a five year follow-up is good, and a ten year follow-up is very good for showing the trend in the treatment of breast cancer.
However, it is emphasized that patients with breast cancer must be followed up even after the ten year period referred to above because there is a four-to five-fold increased risk of contralateral breast cancer (Schoenberg, 1977; Schottenfeld & Berg, 1975) or recurrence. This would maximize the chance of cure and, when necessary, optimize palliation (Horton, 1984) .
